PAPP‐A2 and Inhibin A as Novel Predictors for Pregnancy Complications in Women With Suspected or Confirmed Preeclampsia
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PAPP‐A2 and Inhibin A as Novel Predictors for Pregnancy Complications in Women With Suspected or Confirmed Preeclampsia
Authors
Keywords
-
Journal
Journal of the American Heart Association
Volume 9, Issue 19, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-09-29
DOI
10.1161/jaha.120.018219
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The potential role of pregnancy-associated plasma protein-A2 in angiogenesis and development of preeclampsia
- (2019) Xi Chen et al. HYPERTENSION RESEARCH
- Preeclampsia
- (2019) Sarosh Rana et al. CIRCULATION RESEARCH
- Quantitative differences in TGF-β family members measured in small antral follicle fluids from women with or without PCO
- (2019) Stine Gry Kristensen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Placental effects and transfer of sildenafil in healthy and preeclamptic conditions
- (2019) Emilie Hitzerd et al. EBioMedicine
- Placental proteases PAPP-A and PAPP-A2, the binding proteins they cleave (IGFBP-4 and -5), and IGF-I and IGF-II: Levels in umbilical cord blood and associations with birth weight and length
- (2019) Bridget DiPrisco et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Transfer and Vascular Effect of Endothelin Receptor Antagonists in the Human Placenta
- (2019) Emilie Hitzerd et al. HYPERTENSION
- Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia
- (2018) L. Saleh et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice
- (2018) Mark A. Brown et al. Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health
- Angiogenic Markers Predict Pregnancy Complications and Prolongation in PreeclampsiaNovelty and Significance
- (2017) Langeza Saleh et al. HYPERTENSION
- Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
- (2016) Harald Zeisler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential expression of human placental PAPP-A2 over gestation and in preeclampsia
- (2016) Anita W. Kramer et al. PLACENTA
- Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy
- (2014) Hee Jin Park et al. BMC Pregnancy and Childbirth
- A robust immunoassay for pregnancy-associated plasma protein-A2 based on analysis of circulating antigen: establishment of normal ranges in pregnancy
- (2013) S. Kløverpris et al. MOLECULAR HUMAN REPRODUCTION
- PAPPA2 is increased in severe early onset pre-eclampsia and upregulated with hypoxia
- (2013) Kate Macintire et al. REPRODUCTION FERTILITY AND DEVELOPMENT
- First-Trimester Levels of Pregnancy-Associated Plasma Protein A2 (PAPP-A2) in the Maternal Circulation Are Elevated in Pregnancies That Subsequently Develop Preeclampsia
- (2013) Erin J. Crosley et al. Reproductive Sciences
- Pre-eclampsia
- (2010) Eric AP Steegers et al. LANCET
- Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia
- (2010) J. Yu et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients
- (2008) Haruki Nishizawa et al. MOLECULAR HUMAN REPRODUCTION
- Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity
- (2008) Jin Hee Kang et al. PRENATAL DIAGNOSIS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started